SHIM
IDXX icon

Stone House Investment Management’s Idexx Laboratories IDXX Stock Holding History

Stone House Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$677 – 1108
2025
Q4 		$677 Hold
1
– – ﹤0.01% 691
2025
Q3 		$639 Buy
+1
New +$607 ﹤0.01% 613

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stone House Investment Management's IDXX Position: Q1 2026 in Review

Stone House Investment Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 1 share — an estimated $677 sold.

Stone House Investment Management first reported a position in IDXX in Q3 2025 and held it in 2 quarters. The position peaked at $677 in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Stone House Investment Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Stone House Investment Management sold 1 Idexx Laboratories share in Q1 2026, an estimated $677.
  • Stone House Investment Management first reported a position in Idexx Laboratories in Q3 2025 and held it in 2 quarters.
  • Stone House Investment Management's Idexx Laboratories position peaked at $677 in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.